Clinical Trials Directory

Trials / Completed

CompletedNCT02616900

eSight Eyewear Quality of Life and Efficacy Study

eQUEST -- ESIGHT QUALITY OF LIFE AND EFFICACY STUDY A Multi-center, Prospective Cohort Study to Assess the Impact of eSight Eyewear on Functional Vision Improvement and Quality of Life in a Low Vision Population

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
74 (actual)
Sponsor
eSight Corporation · Industry
Sex
All
Age
13 Years – 75 Years
Healthy volunteers
Accepted

Summary

The "eSight Quality of Life and Efficacy Study" (eQUEST) is a prospective cohort study intended to demonstrate the functional vision and Quality of Life (QoL) improvement provided by eSight Eyewear to persons with significant visual impairment resulting from various eye conditions. The multi-site study will evaluate the efficacy of the eSight device for various Activities of Daily Living (ADLs) across a broad range of subject ages and disease types.

Detailed description

Subjects will receive an initial benchmark assessment to determine their visual function. This includes standard clinical tests for acuity and contrast performance. Subjects will then receive a demonstration of the device. If the demonstration shows favourable results (improved functional visual performance for some rudimentary tasks such as reading), and the subject consents to the study, the subject will return to the site a week later to receive their personalized device (lens prescriptions incorporated into the unit), and more comprehensive training on its operation. They will then use the unit in their home/work/school environment over a period of three months. At the start of the study, after a period of one month, and at the end of the three month period, the subject will visit the clinical setting for administration of various specified ADL tasks, and the Veterans Affairs (VA) Low Vision (LV) Visual Function Questionnaire (VFQ) 48-question VA LV VFQ-48 survey. The intent of this repetition is to understand how ADL proficiency and VFQ-48 QoL assessment changes over time, as the subject becomes more accustomed to the device.

Conditions

Interventions

TypeNameDescription
DEVICEeSight Eyewearprimary intervention

Timeline

Start date
2015-12-16
Primary completion
2017-03-31
Completion
2017-03-31
First posted
2015-11-30
Last updated
2019-04-05
Results posted
2019-04-05

Locations

6 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT02616900. Inclusion in this directory is not an endorsement.